Phibro Animal Health | Capital De Empréstimo





Capital De Empréstimo Alterar Data
Align Technology USD 0 0 2024-12
ANI Pharmaceuticals USD 297.68M 310.67M 2025-09
Assertio Holdings USD 39.17M 120K 2025-09
Aurora Cannabis CAD 34.99M 1.31M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 226.33M 62.67M 2025-09
Eli Lilly USD 40.87B 6.69B 2025-09
Henry Schein USD 2.15B 63M 2025-09
Idexx Laboratories USD 374.84M 17K 2025-12
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Pacira USD 376.72M 1.37M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 7.07B 1.84B 2025-09


Phibro Animal Health Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.